https://www.selleckchem.com/products/ms023.html
1.4.3. The results of this study will be published in a peer-reviewed journal. Our study is expected to provide high-quality, evidence-based recommendations on further treatment of MGH for clinicians. PROSPERO (registration number CRD42020158743). PROSPERO (registration number CRD42020158743). Anticoagulant therapy is used for stroke prevention and proved to be effective and safe in the long term. The study aims to analyse the cost-effectiveness relationship of using of direct-acting oral anticoagulants vs vitamin K antagonists to prevent
Like
Comment
Share
